CAS No.:14060-38-9
Name: ARSENIOUS ACID, SODIUM SALT
Details Introduction
TOXICITY DATA with REFERENCE：
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| frog | LDLo | oral | 600mg/kg (600mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
| frog | LDLo | subcutaneous | 200mg/kg (200mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
| rat | LDLo | intraperitoneal | 9mg/kg (9mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 454, 1936. |
Consensus Reports：
Arsenic and its compounds are on the Community Right-To-Know List.
SAFETY PROFILE：
Confirmed human carcinogen. Poison by intraperitoneal and subcutaneous routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of arsenic.
Standards and Recommendations：
OSHA PEL: TWA 0.01 mg(As)/m3; Cancer Hazard
ACGIH TLV: TWA 0.01 mg/m3; Confirmed Human Carcinogen; BEI: 35 μ (As)/L inorganic arsenic and methylated metabolites in urine
NIOSH REL: (Arsenic, Inorganic) CL 2 µg(As)/m3/15 M
Analytical Methods：
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione